Literature DB >> 4361

Effect of cimetidine on 24-hour intragastric acidity in normal subjects.

R E Pounder, J G Williams, G J Milton-Thompson, J J Misiewicz.   

Abstract

The effect of H2-receptor blockade on intragastric acidity was studied in nine normal males. The pH of their gastric contents was measured at hourly daytime and two hourly nighttime intervals for 48 hours. The subjects ate identical meals, drank identical volumes of fluid, and smoked the same number of cigarettes during the two study days. Their physical activity was unrestricted in a ward environment. Blood cimetidine and plasma gastrin were measured in serial blood samples. The nine subjects were treated in random sequence with cimetidine 0-8-1-0 g on one day and placebo capsules on the other. The drug was given in four divided doses: four subjects received it before, and five after, the three main meals. All took the fourth dose at bedtime. Replicate studies in an additional subject given placebo on both study days showed good reproducibility (r=0-80, P less than 0-01). Cimetidine therapy decreased intragastric acidity in all nine subjects. The decrease was similar in the two groups taking the drug before or after meals, mean 24 h intragastric hydrogen ion activity being lowered by 70 and 72% respectively. Nocturnal anacidity was recorded in only two of 45 samples. Administration of cimetidine before meals produced earlier and higher drug blood levels than post-prandial medication, but when it was taken after food the blood levels were highest at the time when the buffer capacity of the food was waning. Blood concentrations of cimetidine exceeded the secretory IC50 level for most of the time between doses. The results show that cimetidine 0-8-1-0 g/day in four divided doses produces a striking and consistent decrease of intragastric acidity. Although variation in the timing of the dose in relation to meals did not affect the decrease of acidity, the absorption data suggest that patients should take the drug after meals.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4361      PMCID: PMC1411087          DOI: 10.1136/gut.17.2.133

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  EFFECT OF DIFFERENT FOODS ON THE ACIDITY OF THE GASTRIC CONTENTS IN PATIENTS WITH DUODENAL ULCER. I. A COMPARISON BETWEEN TWO 'THERAPEUTIC' DIETS AND FREELY-CHOSEN MEALS.

Authors:  J E LENNARD-JONES; N BABOURIS
Journal:  Gut       Date:  1965-04       Impact factor: 23.059

2.  EFFECT OF DIFFERENT FOODS ON THE ACIDITY OF THE GASTRIC CONTENTS IN PATIENTS WITH DUODENAL ULCER. II. EFFECT OF VARYING THE SIZE AND FREQUENCY OF MEALS.

Authors:  N BABOURIS; J FLETCHER; J E LENNARD-JONES
Journal:  Gut       Date:  1965-04       Impact factor: 23.059

3.  Some Factors in the Assessment of Gastric Antisecretory Drugs by a Sampling Technique.

Authors:  J P Bingle; J E Lennard-Jones
Journal:  Gut       Date:  1960-12       Impact factor: 23.059

4.  Proceedings: New histamine H2-receptor antagonist inhibits food-stimulated gastric acid secretion.

Authors:  R E Pounder; R G Russell; J G Williams; J J Misiewicz; G J Milton-Thompson
Journal:  Gut       Date:  1975-05       Impact factor: 23.059

5.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

6.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

7.  Inhibition of nocturnal acid secretion in duodenal ulcer by one oral dose of metiamide.

Authors:  G J Milton-Thompson; J G Williams; D J Jenkins; J J Misiewicz
Journal:  Lancet       Date:  1974-04-20       Impact factor: 79.321

8.  Determination of pH by the glass electrode: pH meter calibration for gastric analysis.

Authors:  E W Moore
Journal:  Gastroenterology       Date:  1968-04       Impact factor: 22.682

9.  Metiamide--an orally active histamine H2-receptor antagonist.

Authors:  J W Black; W A Duncan; J C Emmett; C R Ganellin; T Hesselbo; M E Parsons; J H Wyllie
Journal:  Agents Actions       Date:  1973-10

10.  The effect of an H2-receptor antagonist on food-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcers. Comparison with an anticholinergic drug.

Authors:  C T Richardson; B A Bailey; J H Walsh; J S Fordtran
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

View more
  33 in total

1.  Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.

Authors:  A B R Thomson; M Keelan; R Lastiwka; S Appelman-Eszczuk; L Zuk; L Drozdowski; A Prentice; P Sinclair
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

2.  Effect of acupuncture on gastric acid secretion in healthy male volunteers.

Authors:  G Tougas; L Y Yuan; J W Radamaker; S G Chiverton; R H Hunt
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

Review 3.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

4.  The preventive effect of cimetidine on producing stress ulcer in rats.

Authors:  K Sugimachi; S Sufian; T Matsumoto; T Nakamura; K Inokuchi
Journal:  Jpn J Surg       Date:  1978-09

5.  Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

Authors:  B K Sharma; R P Walt; R E Pounder; M D Gomes; E C Wood; L H Logan
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

6.  24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine.

Authors:  R E Pounder; R H Hunt; S H Vincent; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

7.  Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonist.

Authors:  J G Mills; P L Brunet; R Griffiths; R H Hunt; D Vincent; G J Milton-Thompson; W L Burland
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

8.  A review of the Zollinger-Ellison syndrome--with particular reference to a patient treated with cimetidine.

Authors:  R J Wyke; G L Hill; A T Axon
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

Review 9.  Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-02       Impact factor: 9.546

10.  Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study.

Authors:  M Deakin; H P Glenny; J K Ramage; J G Mills; W L Burland; J G Williams
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.